---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-189000"
form_type: "8-K"
ticker: "TCRX"
cik: "0001783328"
company_name: "TScan Therapeutics, Inc."
filed_at: "2022-07-07T23:59:59+00:00"
generated_at: "2026-06-24T19:51:08.172385+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# TScan appoints Dr. Debora Barton as Chief Medical Officer effective July 5, 2022

## Summary
- Appointed Dr. Debora Barton as CMO, effective July 5, 2022.
- Barton previously CMO at Carisma Therapeutics and SVP at Iovance Biotherapeutics.
- Employment terms: $450k base salary, option for 150k shares under 2021 equity plan.
- Option vests 25% after 12 months, remainder in 36 monthly installments; eligible for 40% bonus target.
- No family relationships or material transactions with the company.

## SEC filing metadata
- accession: 0001193125-22-189000
- form_type: 8-K
- ticker: TCRX
- cik: 0001783328
- company_name: TScan Therapeutics, Inc.
- filed_at: 2022-07-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783328/000119312522189000/0001193125-22-189000-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783328/000119312522189000/d537481d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-189000
- JSON: https://secwatch.observer/filing/0001193125-22-189000.json
- Plain text: https://secwatch.observer/filing/0001193125-22-189000.txt

## Key facts
- Executive change
  Dr. Debora Barton was appointed as Chief Medical Officer at TScan Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: On July 7, 2022, TScan Therapeutics, Inc. (the “Company”), announced the appointment of Dr. Debora Barton, M.D., to serve as the Company’s Chief Medical Officer, effective July 5, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1783328/000119312522189000/0001193125-22-189000-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.